Clinical Trial

Cardiovascular Risk in Patients With IBD

Study acronym: DICOM-IBD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In this study our Research Hospital San Donato Policlinic ask your partipation with the aim to evaluate the risk of cardiovascular complication (i.e. stroke, myocardial infarction) in patients with inflammatory bowel disease. Multiple parameters (therapy, disease activity, life style) and investigations (DNA, stool, lab tests) will be evaluate with the support of artificial intelligence methodologies to better define the cardiovascular risk.
Trial Details
NCT Number NCT07663201
Lead Sponsor IRCCS Policlinico S. Donato
Collaborators: IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo
Conditions Ulcerative Colitis (UC), Crohn's Diseases, Cardiovascular Risk
Enrollment 300 participants
Start Date 2026-09
Primary Completion 2029-08 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-23